Class A shares of innovative drug sector has repeatedly strengthened, Lianhuan Pharmaceutical went out of 8 days and 6 boards, Yifang Bio rose more than 6%, Lisheng Pharmaceutical, Guangshengtang, Asia Pacific Pharmaceutical, Franc Group, Anglikang rose more than 5%.